Elizabeth R. Duke

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

William A. Fischer, Joseph J. Eron, Wayne Holman et al. · Science Translational Medicine · 2021 · 348 citations · Full text

Molnupiravir, an Oral Antiviral Treatment for COVID-19

William A. Fischer, Joseph J. Eron, Wayne Holman et al. · 2021 · 215 citations · Full text

A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation

Daniel B. Reeves, Elizabeth R. Duke, Thor A. Wagner et al. · Nature Communications · 2018 · 144 citations · Full text

Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation

Danniel Zamora, Elizabeth R. Duke, Hu Xie et al. · Blood · 2021 · 138 citations · Full text

Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19

Matthew G. Johnson, Amy Puenpatom, Pablo Andrés Moncada et al. · Annals of Internal Medicine · 2022 · 67 citations · Full text